Releuko 480 MCG per 0.8 ML Prefilled Syringe

RxCUI
2595962
RxNorm name
Releuko 480 MCG per 0.8 ML Prefilled Syringe
Display name
Releuko 480 MCG per 0.8 ML Prefilled Syringe
Full name
Releuko 480 MCG per 0.8 ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761082Releukofilgrastim-ayow351(k) BiosimilarRx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
74e1ec6e-1630-4654-895c-2bd355f939e7Releuko 480 MCG in 0.8 ML Prefilled Syringe [PSN] · 0.8 ML filgrastim-ayow 0.6 MG/ML Prefilled Syringe [Releuko] [SBD] · Releuko 0.6 MG/ML per 0.8 ML Prefilled Syringe [SY] · Releuko 480 MCG per 0.8 ML Prefilled Syringe [SY]428These highlights do not include all the information needed to use RELEUKO safely and effectively. See full prescribing information for RELEUKO. RELEUKO ® (filgrastim-ayow) injection, for subcutaneous or intravenous use. Initial U.S. Approval: 2022 RELEUKO (filgrastim-ayow) is biosimilar* to NEUPOGEN ® (filgrastim)20250424